AFG2A
Basic information
Region (hg38): 4:122923070-123319433
Previous symbols: [ "SPATA5" ]
Links
Phenotypes
GenCC
Source:
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (Strong), mode of inheritance: AR
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (Definitive), mode of inheritance: AR
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (Supportive), mode of inheritance: AR
- microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities | AR | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic | Although details are unclear, multiple individuals have been described as having immunodefiency, and awareness may allow prompt and aggressive treatment of infections; Among other findings, the condition can include sensorineural hearing loss, and some patients may benefit from early recognition and management of hearing loss | Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Hematologic; Neurologic | 21822266; 26299366 |
ClinVar
This is a list of variants' phenotypes submitted to
- Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome (44 variants)
- not provided (8 variants)
- Inborn genetic diseases (2 variants)
- Neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AFG2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 141 | 147 | ||||
missense | 17 | 313 | 340 | |||
nonsense | 22 | 29 | ||||
start loss | 2 | |||||
frameshift | 19 | 23 | ||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 11 | |||||
splice region | 17 | 19 | 3 | 39 | ||
non coding | 77 | 37 | 119 | |||
Total | 47 | 39 | 326 | 220 | 44 |
Highest pathogenic variant AF is 0.000171
Variants in AFG2A
This is a list of pathogenic ClinVar variants found in the AFG2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-122923141-C-T | Uncertain significance (Apr 07, 2021) | |||
4-122923143-A-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome • not specified | Conflicting classifications of pathogenicity (Mar 12, 2024) | ||
4-122923143-A-G | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Jul 05, 2022) | ||
4-122923143-A-T | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Aug 27, 2021) | ||
4-122923144-T-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Conflicting classifications of pathogenicity (Aug 23, 2022) | ||
4-122923146-T-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Aug 26, 2021) | ||
4-122923151-CAAG-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Jan 01, 2019) | ||
4-122923152-A-T | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Pathogenic (Dec 24, 2021) | ||
4-122923155-A-G | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Sep 13, 2022) | ||
4-122923156-A-G | Uncertain significance (Jan 10, 2020) | |||
4-122923157-G-A | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Likely benign (May 31, 2022) | ||
4-122923157-G-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Jun 30, 2022) | ||
4-122923158-A-G | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome • Inborn genetic diseases | Uncertain significance (Oct 13, 2022) | ||
4-122923168-G-A | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Apr 23, 2022) | ||
4-122923170-T-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Likely benign (Apr 23, 2021) | ||
4-122923181-C-T | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Likely benign (Jul 04, 2022) | ||
4-122923187-A-C | Uncertain significance (Apr 04, 2019) | |||
4-122923196-G-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Likely benign (Jul 05, 2022) | ||
4-122923199-C-T | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Likely benign (May 03, 2022) | ||
4-122923201-T-C | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Mar 23, 2022) | ||
4-122923203-C-T | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome • Inborn genetic diseases | Conflicting classifications of pathogenicity (Nov 22, 2023) | ||
4-122923207-C-G | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Apr 16, 2018) | ||
4-122923213-C-G | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Uncertain significance (Aug 27, 2021) | ||
4-122923216-C-G | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
4-122923217-C-T | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | Likely benign (Jan 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AFG2A | protein_coding | protein_coding | ENST00000274008 | 16 | 396377 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.08e-20 | 0.0558 | 125625 | 0 | 123 | 125748 | 0.000489 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.460 | 446 | 474 | 0.941 | 0.0000232 | 5803 |
Missense in Polyphen | 151 | 182.91 | 0.82556 | 2171 | ||
Synonymous | 0.601 | 163 | 173 | 0.942 | 0.00000844 | 1790 |
Loss of Function | 1.14 | 34 | 42.0 | 0.810 | 0.00000250 | 504 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000606 | 0.000603 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000498 | 0.000489 |
Finnish | 0.000278 | 0.000277 |
European (Non-Finnish) | 0.000710 | 0.000703 |
Middle Eastern | 0.000498 | 0.000489 |
South Asian | 0.000328 | 0.000327 |
Other | 0.000656 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: ATP-dependent chaperone which uses the energy provided by ATP hydrolysis to generate mechanical force to disassemble protein complexes. May be involved in morphological and functional mitochondrial transformations during spermatogenesis. {ECO:0000250|UniProtKB:P32794, ECO:0000250|UniProtKB:Q3UMC0}.;
- Disease
- DISEASE: Epilepsy, hearing loss, and mental retardation syndrome (EHLMRS) [MIM:616577]: An autosomal recessive disorder characterized by intellectual disability, intractable epilepsy, microcephaly, abnormal muscle tone, and sensorineural hearing loss. {ECO:0000269|PubMed:26299366}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.181
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.66
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- N
- hipred_score
- 0.204
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.385
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spata5
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- spermatogenesis;brain development;cell differentiation
- Cellular component
- cytoplasm;mitochondrion
- Molecular function
- ATP binding;ATPase activity